Cambridge, MA, United States of America

Mary M Mader

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: D.e. Shaw Research, LLC, Relay Therapeutics, Inc., University of California. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary M Mader. Retrieved from https://idiyas.com/inventor/mary-m-mader

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mary M Mader - Innovator in Pharmaceutical Research

Introduction: Mary M Mader is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds and methods for treating disorders associated with PI3Kα signaling. Although she currently holds no granted patents, her work is noteworthy for its potential impact on medical treatments.

Latest Patent Applications: Mary M Mader's latest patent applications include "PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF." This application relates to novel compounds and pharmaceutical compositions designed to inhibit the activity of PI3Kα enzymes. The disclosure further outlines methods for treating disorders associated with PI3Kα signaling using these compounds and compositions.

Conclusion: Mary M Mader's innovative work in pharmaceutical research highlights her dedication to advancing medical science, even in the absence of granted patents. Her contributions may pave the way for future breakthroughs in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…